A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y

Molecular and Cellular Biology

Volumn 20, Issue 10, 2000, Pages 3364-3376

  Villard, Jean ^a   Peretti, Marie ^a   Masternak, Krzysztof ^a   Barras, Emmanuèle ^a   Caretti, Giuseppina ^b   Mantovani, Roberto ^b   Reith, Walter ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; REGULATOR PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; DNA SEQUENCE; GENE ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; CCAAT-ENHANCER-BINDING PROTEINS; CONSERVED SEQUENCE; DNA-BINDING PROTEINS; GENETIC COMPLEMENTATION TEST; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0034096381     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.10.3364-3376.2000     Document Type: Article

References (79)

1. Alber, T. 1992. Structure of the leucine zipper. Curr. Opin. Genet. Dev. 2:205-210.
2. Batchelor, A. H., D. E. Piper, F. C. de la Brousse, S. L. McKnight, and C. Wolberger. 1998. The structure of GABPalpha/beta: an ETS domain-ankyrin repeat heterodimer bound to DNA. Science 279:1037-1041.
3. Benichou, B., and J. L. Strominger. 1991. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA 88:4285-4288.
4. Bontron, S., C. Ucla, B. Mach, and V. Steimle. 1997. Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy. Mol. Cell. Biol. 17:4249-4258.
5. Boss, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107-113.
6. Bottazzo, G. F., I. Todd, R. Mirakian, A. Belfiore, and R. Pujol-Borrell. 1986. Organ-specific autoimmunity: a 1986 overview. Immunol. Rev. 94:137-169.
7. Brickley, W., K. Wright, X. Zhu, and J. Ting. 1999. Analysis of the defect in INF-gamma induction of MHC class II genes in GIB cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the RFX5 transcription factor. J. Immunol. 163:6622-6630.
8. Brocker, T. 1997. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J. Exp. Med. 186:1223-1232.
9. Buchanan, S. G., and N. J. Gay. 1996. Structural and functional diversity in the leucine-rich repeat family of proteins. Prog. Biophys. Mol. Biol. 65:1-44.
10. Bull, M., A. van Hoef, and J. Gorski. 1990. Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction. Mol. Cell. Biol. 10:3792-3796.
11. Casper, J. T., R. A. Ash, P. Kirchner, J. B. Hunter, P. L. Havens, and M. J. Chusid. 1990. Successful treatment of an HLA-deficient SCID ("bare lymphocyte syndrome") patient with an unrelated bone marrow transplant. J. Pediatr. 116:262-265.
12. Charron, D. J., and H. O. McDevitt. 1979. Analysis of HLA-D region-associated molecules with monoclonal antibody. Proc. Natl. Acad. Sci. USA 76:6567-6571.
13. Clausen, B., J. Waldburger, F. Schwenk, E. Barras, B. Mach, K. Rajewski, I. Förster, and W. Reith. 1998. Residual MHC class II expression on mature dentritic cells and activated B cells in RFX5-deficient mice. Immunity 8:143-155.
14. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293.
15. Curran, J., R. Boeck, N. Lin-Marq, A. Lupas, and D. Kolakofsky. 1995. Paramyxovirus phosphoproteins form homotrimers as determined by an epitope dilution assay, via predicted coiled coils. Virology 214:139-149.
16. Currie, R. A. 1998. Biochemical characterization of the NF-Y transcription factor complex during B lymphocyte development. J. Biol. Chem. 273:18220-18229.
17. DeSandro, A., U. M. Nagarajan, and J. M. Boss. 1999. The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes. Am. J. Hum. Genet. 65:279-286.
18. Durand, B., M. Kobr, W. Reith, and B. Mach. 1994. Functional complementation of MHC class II regulatory mutants by the purified X box binding protein RFX. Mol. Cell. Biol. 14:6839-6847.
19. Durand, B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16:1045-1055.
20. Elhasid, R., and A. Etzioni. 1996. Major histocompatibility complex class II deficiency: a clinical review. Blood Rev. 10:242-248.
21. Emery, P., B. Durand, B. Mach, and W. Reith. 1996. RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res. 24:803-807.
22. Emery, P., M. Strubin, K. Hofmann, P. Bucher, B. Mach, and W. Reith. 1996. A consensus motif in the RFX DNA binding domain and binding domain mutants with altered specificity. Mol. Cell. Biol. 16:4486-4494.
23. Fondaneche, M. C., J. Villard, W. Wiszniewski, E. Jouanguy, A. Etzioni, F. Le Deist, A. Peijnenburg, J. L. Casanova, W. Reith, B. Mach, A. Fischer, and B. Lisowska-Grospierre. 1998. Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum. Mol. Genet. 7:879-885.
24. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
25. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13-49.
26. Guardiola, J., and A. Maffei. 1993. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. Crit. Rev. Immunol. 13:247-268.
27. Hanenberg, H., X. Xiao, D. Dillo, K. Hashino, I. Kato, and D. Williams. 1996. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat. Genet. 2:876-882.
28. Hasegawa, S. L., and J. M. Boss. 1991. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters. Nucleic Acids Res. 19:6269-6276.
29. Herrero Sanchez, C., W. Reith, P. Silacci, and B. Mach. 1992. The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters. Mol. Cell. Biol. 12:4076-4083.
30. Janeway, C. A. 1994. Thymic selection: two pathways to life and two to death. Immunity 1:3-6.
31. Jang, S. K., and K. Wimmer. 1990. Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev. 4:1560-1572.
32. Kara, C. J., and L. H. Glimcher. 1991. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252:709-712.
33. Kara, C. J., and L. H. Glimcher. 1993. Three in vivo promoter phenotypes in MHC class II deficient combined immunodeficiency. Immunogenetics 37: 227-230.
34. Klein, C., B. Lisowska Grospierre, F. LeDeist, A. Fischer, and C. Griscelli. 1993. Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J. Pediatr. 123:921-928.
35. Kumar, V., and P. Chambon. 1988. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55:145-156.
36. Liberati, C., A. di Silvio, S. Ottolenghi, and R. Mantovani. 1999. NF-Y binding to twin CCAAT boxes: role of Q-rich domains and histone fold helices. J. Mol. Biol. 285:1441-1455.
37. Lisowska-Grospierre, B., M. C. Fondaneche, M. P. Rols, C. Griscelli, and A. Fischer. 1994. Two complementation groups account for most cases of inherited MHC class II deficiency. Hum. Mol. Genet. 3:953-958.
38. Louis-Plence, P., C. Moreno, and J. Boss. 1997. Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol. 159: 3899-3909.
39. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996 Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301-331.
40. Mantovani, R. 1999. The molecular biology of the CAAT-binding factor NF-Y. Gene 239:15-27.
41. Mantovani, R., U. Pessara, F. Tronche, X. Y. Li, A. M. Knapp, J. L. Pasquali, C. Benoist, and D. Mathis. 1992. Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription. EMBO J. 11:3315-3322.
42. Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J. C. Sanchez, D. F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20:273-277.
43. Moreno, C. S., G. W. Beresford, P. Louis-Plence, A. C. Morris, and J. M. Boss. 1999. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10:143-151.
44. Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, B. Mach, and J. M. Boss. 1995. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:4313-4321.
45. Muhlethaler-Mottet, A., W. Di Berardino, L. A. Otten, and B. Mach. 1998. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1. Immunity 8:157-166.
46. Muhlethaler-Mottet, A., L. A. Otten, V. Steimle, and B. Mach. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:2851-2860.
47. Nagarajan, U. M., P. Louis-Plence, A. DeSandro, R. Nilsen, A. Bushey, and J. M. Boss. 1999. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10:153-162.
48. Naldini, L. 1998. Lentiviruses as gene transfer agents for delivery to nondividing cells. Curr. Opin. Biotechnol. 9:457-463.
49. Naldini, L., U. Blömer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of non dividing cells by a lentiviral vector. Science 272:263-267.
50. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
51. Page, K. A., N. R. Landau, and D. R. Littman. 1990. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:5270-5276.
52. Peijnenburg, A., M. C. Van Eggermond, S. J. Gobin, R. van den Berg, B. C. Godthelp, J. M. Vossen, and P. J. van den Elsen. 1999. Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5. J. Immunol. 163:794-801.
53. Peijnenburg, A., M. C. van Eggermond, R. van den Berg, O. Sanal, J. M. Vossen, and P. J. van den Elsen. 1999. Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene. Immunogenetics 49:338-345.
54. Reith, W., V. Steimle, B. Lisowska-Grospierre, A. Fischer, and B. Mach. 1999. Molecular basis of major histocompatibility complex class II deficiency, p. 167-180. In H. Ochs, C. Smith, and J. Puck (ed.), Primary immunodeficiency diseases. Oxford University Press, New York, N.Y.
55. Reith, W., M. Kobr, P. Emery, B. Durand, C. A. Siegrist, and B. Mach. 1994. Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J. Biol. Chem. 269:20020-20025.
56. Reith, W., S. Satola, C. Herrero Sanchez, I. Amaldi, B. Lisowska-Grospierre, C. Griscelli, M. R. Hadam, and B. Mach. 1988. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53:897-906.
57. Reith, W., C. A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91: 554-558.
58. Reith, W., C. Ucla, E. Barras, A. Gaud, B. Durand, C. Herrero Sanchez, M. Kobr, and B. Mach. 1994. RFX1, a transactivator of hepatitis B virus enhancer 1, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins. Mol. Cell. Biol. 14:1230-1244.
59. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box and the class II transactivator (CIITA). Immunity 2:533-543.
60. Rooke, R., C. Waltzinger, C. Benoist, and D. Mathis. 1997. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. Immunity 7:123-134.
61. Scholl, P. R., and R. S. Geha. 1994. MHC class II signaling in B-cell activation. Immunol. Today 15:418-422.
62. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94:6330-6334.
63. Sedgwick, S. G., and S. J. Smerdon. 1999. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 24: 311-316.
64. Seidl, C., C. Saraiya, Z. Osterweil, Y. P. Fu, and J. S. Lee. 1992. Genetic complexity of regulatory mutants defective for HLA class-II gene-expression. J. Immunol. 148:1576-1584.
65. Serra, E., K. Zemzoumi, A. di Silvio, R. Mantovani, V. Lardans, and C. Dissous. 1998. Conservation and divergence of NF-Y transcriptional activation function. Nucleic Acids Res. 26:3800-3805.
66. Silvio, A., C. Imbriano, and R. Mantovani. 1999. Dissection of the NF-Y transcriptional activation potential. Nucleic Acids Res. 27:2578-2584.
67. Steimle, V., B. Durand, E. Barras, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021-1032.
68. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146.
69. Steimle, V., C. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106-109.
70. Takeda, S., H. R. Rodewald, H. Arakawa, H. Bluethmann, and T. Shimizu. 1996. MHC class II molecules are not required for survival of newly generated CD4+ T cells, but affect their long-term life span. Immunity 5:217-228.
71. Ting, J. P. Y., and A. S. Baldwin. 1993. Regulation of MHC gene expression. Curr. Opin. Immunol. 5:8-16.
72. Villard, J., B. Lisowska-Grospierre, P. van den Elsen, A. Fischer, A. Reith, and B. Mach. 1997. Primary MHC class II deficiency: genetic and molecular definition of a novel complementation group. N. Engl. J. Med. 337:748-753.
73. Villard, J., W. Reith, E. Barras, A. Gos, M. A. Morris, S. E. Antonarakis, P. J. van den Elsen, and B. Mach. 1997. Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency. Hum. Mutat. 10:430-435.
74. Westerheide, S. D., and J. M. Boss. 1999. Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer. Nucleic Acids Res. 27:1635-1641.
75. Wright, K. L., B. J. Vilen, Y. Itoh Lindstrom, T. L. Moore, G. Li, M. Criscitiello, P. Cogswell, J. B. Clarke, and J. P. Ting. 1994. CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J. 13:4042-4053.
76. Zeleznik Le, N. J., J. C. Azizkhan, and J. P. Ting. 1991. Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 88:1873-1877.
77. Zemzoumi, K., M. Frontini, M. Bellorini, and R. Mantovani. 1999. NF-Y histone fold alpha1 helices help impart CCAAT specificity. J. Mol. Biol. 286:327-337.
78. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545-553.
79. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.